Hydrogen Water and Skin: What a 2026 Randomized Trial and Recent Research Suggest

Hydrogen Water and Skin: What a 2026 Randomized Trial and Recent Research Suggest

In January 2026, plastic surgeons at Peking Union Medical College Hospital published the first randomized, double-blinded trial of hydrogen-rich water for a skin condition. It is a small trial. The condition is keloids — a thick, raised, often itchy scar that almost nothing in dermatology can comfortably treat. And the result is one of the more interesting signals to come out of the molecular hydrogen literature in years. Kuang and colleagues reported, in Aesthetic Plastic Surgery, that keloid patients who drank hydrogen-rich water for a defined treatment window had significantly less pain, significantly less itch, lower scar-scale severity, and measurable shifts in the cytokines that drive scar formation. Not a cure. Not a definitive endpoint. But the first peer-reviewed RCT to take a skin question to hydrogen and find a signal — and a useful entry point into the broader research on skin, oxidative stress, and what the published evidence does and does not say.

The reason the keloid study matters extends well past keloids. Skin is a high-oxidative-stress organ — facing UV, pollution, friction, and the same inflammatory load every other tissue carries. Researchers have been exploring whether hydrogen's selective antioxidant behavior, first proposed by Ohsawa and colleagues in Nature Medicine in 2007, could be relevant to a long list of skin questions: inflammation, photoaging, wound healing, pigmentation, barrier function. Several lines of research have moved forward at once. None of them is a finished case. All of them are worth understanding before the next round of marketing oversimplifies what the studies actually say.

The Oxidation Problem the Skin Has Been Trying to Solve

Skin is the body's exposed antioxidant front line. Sunlight, smoke, ozone, friction, even ordinary metabolism all generate reactive oxygen species in skin tissue. Some of these molecules — like hydrogen peroxide at low concentrations — are signaling agents the body uses on purpose. Others — particularly the hydroxyl radical and peroxynitrite — damage lipids, proteins, and DNA without any redeeming role. That second category is what cosmetics chemists have been chasing for decades.

What "reactive oxygen species" actually do in skin

The damage shows up in concrete, measurable ways. Lipid peroxidation in the skin barrier raises transepidermal water loss, which dermatologists abbreviate as TEWL. Oxidized collagen fragments accumulate in the dermis. Pigmentation pathways are turned on through melanocyte signaling. Keratinocytes — the cells that build the epidermis — start dividing in patterns that, depending on the trigger, can look like psoriasis, eczema, or simply accelerated aging. Reviewers of the field tend to converge on the same conclusion: oxidative stress is a load-bearing variable across a wide range of skin conditions, and the question is not whether it matters but which oxidants matter most.

Why most topical antioxidants don't reach where they need to go

Vitamin C serums, vitamin E creams, polyphenol extracts — most of the antioxidants on a drugstore shelf were developed for the surface of the stratum corneum. They neutralize what they touch. The harder problem is that the most damaging oxidants are generated several layers deep, where a serum doesn't penetrate. A molecule small enough to diffuse through the skin, into the cell, and across the mitochondrial membrane is rare. Molecular hydrogen has that property — it is the smallest molecule that exists. Whether that translates into a benefit in skin is a separate question, and one researchers have only recently started to ask in controlled trials.

What the 2026 Keloid Trial Actually Reported

The headline result is worth stating precisely, because the study is a pilot and the patient count is small. Kuang et al. (2026) enrolled 21 keloid patients who were scheduled for two-stage surgical operations and randomly assigned them to receive hydrogen-rich water or placebo water as part of their pre- and post-operative routine. The trial was double-blinded — neither the patients nor the assessors knew which group received which. Inflammation, scar-formation, and symptom cytokines were measured before and after the intervention using Western blot, qPCR, and ELISA.

The trial design — small, controlled, double-blinded

Twenty-one patients is a pilot. The researchers are explicit about that — they describe their work as exploratory and call for larger confirmatory trials. The point of a pilot is not to settle the question. It is to find out whether the signal is strong enough to justify the larger trial. The design itself, though, sits at a higher tier than most hydrogen-water research has historically operated at. Randomized. Placebo-controlled. Double-blinded. Mechanistic readouts at the protein and gene level, not just patient-reported symptoms.

What changed for the patients

The treatment group reported significantly lower frequency of pain and pruritus after hydrogen-rich water therapy. The Vancouver Scar Scale and pigmentation domain scores both decreased significantly. At the molecular level, expression of TRPV1 (a pruritus-related cytokine receptor) and HIF-1α (a keloid-related signaling molecule) decreased. The anti-inflammatory cytokine IL-10 increased. The pro-inflammatory cytokines VEGF and TGF-β decreased. The authors concluded that hydrogen-rich water therapy "appears to be a safe and promising approach for symptom relief and inflammation modulation in keloid patients."

It is worth pulling out what the trial did not claim. It did not claim a cure. It did not claim keloids were eliminated. It did not propose hydrogen water as a replacement for surgical, intralesional, or pressure-based keloid management. The framing the researchers used — "early clinical signals supporting further large-scale investigation" — is the framing every honest pilot trial uses, and it is the framing we are sticking to here.

The Selectivity Hypothesis Behind These Findings

What "selective antioxidant" means in practice

Why would a small molecule that we exhale every time we breathe show up in a keloid trial at all? The working hypothesis traces to Ohsawa and colleagues (2007), who proposed in Nature Medicine that hydrogen behaves as a selective antioxidant. In their model, hydrogen reacts preferentially with the hydroxyl radical — the most damaging reactive oxygen species — and not with the lower-energy oxidants that the body uses for signaling. That is a different mode of action than vitamin C, which broadly neutralizes whatever it encounters, and a different mode than a polyphenol cream, which mostly stays on the surface.

The selectivity story is still a working hypothesis — not a closed case — but it explains why hydrogen would not blunt the useful oxidants the skin needs for barrier signaling while still tamping down the damaging ones that drive scar formation, photoaging, and chronic inflammation. The cytokine pattern Kuang's group reported (IL-10 up, VEGF and TGF-β down) is consistent with that picture. So is the pattern reported in animal models of psoriasis. So is the cytokine signature in the chronic UVB-exposed mouse-skin model published in 2026. Different teams, different models, similar shape of result.

A 4-Week Pilot of Topical Hydrogen Water in Healthy Adults

Drinking is not the only delivery method researchers are testing. Debkowska and colleagues (2025) ran a four-week open-label pilot of topical hydrogen-rich water in 15 healthy adults, published in the journal Antioxidants. The participants applied hydrogen-rich water to facial skin daily. Skin parameters — porphyrin levels, pigmentation irregularities, pore size, wrinkle severity, and a calculated "biological skin age" — were quantitatively measured before and one week after the treatment period.

What the pilot measured

The standout finding was a statistically significant reduction in pore visibility, particularly in younger participants. Pigmentation irregularities improved on average. Wrinkle severity scores trended down. Biological skin age estimates trended down. None of these are dramatic numbers in a pilot of 15 people without a control group — and the authors say so directly — but the direction of every measured parameter was the same, and the treatment was well tolerated with no adverse effects reported. The researchers framed their pilot as a "gap-closing" step in the literature on topical hydrogen, and a justification for larger controlled studies. The Lourdes Hydrofix Premium Edition, as a drinking-water generator, is not a topical product — but the pilot is useful context for what researchers are exploring at the skin surface.

Hydrogen-Rich Bath and Psoriasis: What the Animal Models Suggest

Two recent animal studies have tested hydrogen-water bathing in a psoriasis-like skin model. In Zhang et al. (2023), mice with imiquimod-induced psoriasis were bathed in hydrogen-rich water or distilled water. The hydrogen-rich water group showed lower psoriasis severity index scores, less abnormal keratosis on histology, lower peak levels of IL-17, IL-23, TNF-α, and lower malondialdehyde — a standard marker of oxidative damage. Wu et al. (2026) followed up by examining the molecular mechanism, finding that hydrogen treatment in the same model dampened the cGAS-STING pathway — a recently characterized innate immune signaling axis that drives inflammatory skin proliferation.

Animal models are not human trials. A mouse psoriasis model is a useful first probe for an immune-driven skin question, not a treatment recommendation. The authors of both papers say the same thing: their results suggest hydrogen could function as a potential adjunct treatment for psoriasis-like inflammation, and that human trials are the next step. The takeaway from these papers is the consistency of the cytokine signature, not the size of any individual effect.

Photoaging, UV Damage, and Hydrogen in a 20-Week Mouse Study

The skin-aging research community has been asking for years whether antioxidant strategies could blunt the chronic, inflammation-driven part of photoaging. Hori and colleagues (2026) ran a 20-week protocol in hairless mice exposing the dorsal skin to UVB three times per week, while one group received continuous hydrogen exposure (a combination of 2% hydrogen gas inhalation and hydrogen-rich drinking water) and the control group received normal air and dehydrogenated water. The protocol was replicated in two independent series.

The hydrogen-treated mice showed delayed onset of UVB-induced skin papillomas and a reduced cumulative tumor count across both experimental series. Importantly, the DNA-photolesion marker (cyclobutane pyrimidine dimers) was unchanged — meaning hydrogen did not reduce the initial DNA damage from UVB. What it appeared to modulate was the chronic inflammatory aftermath: epidermal T-cell infiltration decreased, dermal IL-6 decreased, nuclear phosphorylated STAT3 decreased, and the GSH/GSSG redox ratio was better preserved after acute UVB challenge. The picture the authors paint is of hydrogen attenuating inflammation-associated, post-UV signaling — not of hydrogen acting as a sunscreen. A different role, and one that may map onto how researchers think about photoaging more broadly.

Wound Healing and Re-Epithelialization in the Lab

Faster wound healing is one of the older threads in the hydrogen-and-skin literature, and it is largely preclinical. Zhao and colleagues (2023), working from a hydrogen research center in Beijing, established a cutaneous aseptic wound model in mice and applied a high concentration of hydrogen gas in a treatment chamber. The hydrogen-treated wounds closed roughly three times faster at day 11 than controls. The mechanism the authors found was unexpected: hydrogen appeared to accelerate the proliferation of epidermal stem cells, push them into earlier differentiation into myoepithelial cells, and trigger faster deposition of dermal collagen-I, epidermal collagen-III, and the dermis–epidermis junction collagen-XVII.

The interpretation the researchers offer is that hydrogen may sit upstream of both inflammation and tissue repair — keeping mitochondrial function intact through the stress of wound closure and letting the stem-cell program proceed faster. That is a preclinical finding in mice, and the journey from a mouse wound to a clinical wound-care protocol is long. But it is one of the few studies in the field to actually identify a mechanism that is not "antioxidant in a general sense."

The Aging-Skin Question and a 6-Month Older-Adults Trial

The aging-skin question is the most consumer-facing piece of the literature, and it is also the most cautious. Zanini and colleagues (2021) ran a 6-month randomized controlled pilot trial of hydrogen-rich water versus control water in 40 adults aged 70 and over (registered as NCT04430803). The trial included a long panel of aging biomarkers: telomere length, DNA methylation, brain metabolism, cognitive function, body composition, sleep — and facial skin features.

The facial-skin secondary endpoint

The headline finding from that trial was a treatment-by-time interaction on telomere length favoring the hydrogen-water group. Brain metabolite signals shifted in the hydrogen group as well. The facial-skin features were reported as a secondary outcome with no statistically significant between-group difference at the trial's small sample size — but the authors framed all of these readouts as biomarkers of biological aging and called for larger trials. Importantly, the safety profile across six months of daily intake in older adults was clean. For a population that is often excluded from intervention trials, that piece alone matters. (For a fuller look at the molecular-aging side of the same trial, see our aging research summary, the broader inflammation literature review, and the parallel bone-and-fracture research where the same trial's lower-body strength improvement intersects with the skeletal literature.)

What This Means for the Equipment You Drink From

Given these research findings — a 2026 keloid RCT in humans, a four-week topical pilot, two mouse-model psoriasis studies, a 20-week photoaging study, a wound-healing mechanism paper, and a 6-month older-adults trial — here's how the engineering of a hydrogen water generator maps onto the science. The published clinical trials we keep citing did not use a generic hydrogen liquid pulled off a shelf. They used hydrogen water produced under controlled laboratory conditions, at concentrations matched to the protocol, with verified purity. Replicating that context daily, at home, is an equipment question. The Lourdes Hydrofix Premium Edition is designed to deliver both — adequate concentration and verified purity — in a single countertop unit.

You can find the Lourdes Hydrofix in our hydrogen water machine collection.

Concentration and purity, not one or the other

Concentration matters. Purity matters at least as much. A daily-use device must clear both bars at once — high enough dissolved hydrogen (up to approximately 1.6 ppm under normal conditions for the Hydrofix) to align with the protocols used in the published research, and a water-purity profile that doesn't reintroduce the very oxidative inputs the hydrogen is meant to offset. The professional-strength positioning of the Hydrofix rests on that combination, not on a single PPM number on a marketing page.

The separate-chamber question

One of the engineering decisions inside a hydrogen water generator is whether the electrolysis happens in the same chamber as your drinking water or in a separate, isolated chamber. The Hydrofix uses a separate-chamber (dual-chamber) electrolysis system with a multi-layer fibriform polymer membrane (MFPM). This keeps the electrolysis byproducts isolated from the drinking water — which is why David, an Indiana wellness practitioner who has owned his Hydrofix for three years, bought a hydrogen meter and verified that the only thing crossing into his glass was hydrogen gas. (We covered the engineering case for separate-chamber design in detail in our electrolysis comparison and the broader purity-test breakdown.)

Why an individual certificate of authenticity matters

Every Lourdes Hydrofix is individually tested for hydrogen output before it leaves the factory and ships with a unit-specific certificate of authenticity. That is uncommon in the category. Behind the headline marketing figure of approximately 120 mL/min, the device's hydrogen output was independently verified by a third-party testing lab — Masa International Corp., Test No. MM03-6024-01 — at approximately 134.2 mL/min under their test certificate's specified conditions. The water-purity certificate from Japan Food Research Laboratories (No. 23028707001-0201) reported that selected plasticizers, BPA, iron, and titanium were not detected. The metallurgical certificate for the electrode material (No. 17-MANS-0078-B) documents TP270C high-purity titanium at 99.928% purity. These numbers are the substance behind why a device matters at all when the studies are about dissolved hydrogen and water purity rather than a brand. (See also our electrode-quality deep dive.)

What Daily Use Actually Looks Like, From Two Owners

A researcher and a 92-year-old, drinking the same water

The published research and the certificates can describe what a hydrogen water generator is. What the research can't show is what a daily glass actually looks like in a household. Two owners — David, an Indiana wellness researcher, and Paula, a 92-year-old in California — describe two very different routes to the same habit, and both are useful context for anyone weighing the equipment question against the body of skin and aging research.

David, the Indiana wellness practitioner mentioned earlier, is a fifteen-year researcher of wellness modalities — ketogenic nutrition, light therapy, infrared saunas, cold thermogenesis, qigong, every protocol you've heard a podcast describe. He is also a self-described skeptic. What pulled him toward molecular hydrogen wasn't a testimonial; it was the published literature and the biological rationale. "I was drawn to the emerging research and the biological rationale of molecular hydrogen," he recalls. "This wasn't just some wellness biohack promoted by an influencer." When his Hydrofix arrived, David did what a researcher does — he bought his own hydrogen meter and tested the output independently. It read 1.7 to 1.8 ppm of dissolved hydrogen. Three years and tens of thousands of glasses later, he ran the test again. Same reading. His experience of the daily habit is unflashy. "I just feel well," he says. The trust comes from the engineering, not from a feature he reports overnight.

The contrast with Paula is sharp and useful. Paula is 92. She began drinking one liter of hydrogen-rich water daily in March 2024, after her daughter Pamela read the research and brought the idea home. Paula's habit is the opposite of a protocol — it is a routine. A glass each evening, delivered by her daughter. "Are you coming to bring my water tonight?" became Paula's regular evening question. No decision tree. No calibration period. Paula calls it "my special water." Friends at her senior living community say she looks like a movie star. The reason Paula's story is worth telling next to David's is that the same machine fits both lives — a researcher who wants to verify the output, and a 92-year-old who wants a simple glass that arrives each evening.

What both routines share is the absence of complication. David's daily glass takes the same minute Paula's takes. Neither owner is calibrating, troubleshooting, or running a maintenance protocol. That ease-of-ownership is the part of the Hydrofix that doesn't show up in any peer-reviewed paper — and the part most likely to determine whether a household actually drinks hydrogen water every day, year after year. Useful research is one thing. A glass that gets poured is another.

The Practical Pour

What the literature suggests for a reader who wants to align with the protocols studied is unflashy. Many users drink two large glasses (roughly 500–600 mL each) of hydrogen-rich water in the morning, before eating, and another glass in the evening — about two liters across the day. Fresh from the device is the version most aligned with what the trials used. The water tastes like water. The pH is essentially unchanged from the source water (the Hydrofix maintains pH within about 0.1 of the input). And after the first week of pouring, most owners report the habit has slipped into the same category as brushing teeth — something you do without thinking about it.

None of this is a treatment plan. The studies on skin we've covered — keloids, psoriasis-like inflammation, photoaging, wound healing, aging-skin biomarkers — are pilots and animal models. The 2026 keloid RCT is the strongest human signal in the dermatology-adjacent literature, and it is still a pilot. Researchers continue to investigate. We continue to read the papers as they publish. And the daily habit is just a daily habit.

Further Reading

For the broader PubMed literature on hydrogen-rich water and skin, see PubMed's full results for hydrogen-rich water and skin.

  • Guo N, Zhang Y (2025), Clinical, Cosmetic and Investigational Dermatology. PMID: 40061044. A 2025 review of molecular hydrogen in skin cosmetology — the broadest current synthesis of mechanisms (selective antioxidation, anti-inflammatory action, signaling-pathway modulation) and the clinical signals reported for acne, chloasma, and sensitive skin.
  • Kuang X et al. (2026), Aesthetic Plastic Surgery. PMID: 41545661. The first double-blinded randomized pilot trial of hydrogen-rich water for keloid management — the anchor study for this article. Reported significant reductions in pain, pruritus, scar-scale severity, and pigmentation, with corresponding cytokine shifts.
  • Hori F et al. (2026), International Journal of Molecular Sciences. PMID: 41596287. A 20-week mouse protocol of chronic UVB exposure with continuous hydrogen. Hydrogen-treated mice showed delayed onset of UVB-induced papillomas and reduced cumulative tumor counts, attributed to modulation of the IL-6/STAT3 and ERK/JNK inflammatory pathways.
  • Bajgai J et al. (2021), Current Pharmaceutical Design. PMID: 32981497. A focused review of molecular hydrogen in skin diseases and beauty — covers oxidative stress as a driver of psoriasis, atopic dermatitis, and aging, and surveys how the early hydrogen research maps onto each.
  • Zhao P et al. (2023), Inflammation and Regeneration. PMID: 36973725. A mouse cutaneous wound model showing roughly 3-fold faster healing with high-concentration hydrogen exposure, via accelerated epidermal stem cell proliferation and extracellular matrix deposition.
  • Zhang X et al. (2023), Experimental Dermatology. PMID: 37391861. An earlier mouse model of imiquimod-induced psoriasis bathed in hydrogen-rich water versus distilled water. Reported lower psoriasis severity, lower IL-17, IL-23, TNF-α, and reduced malondialdehyde (a marker of oxidative damage).
  • Debkowska N et al. (2025), Antioxidants (Basel). PMID: 40563361. A four-week open-label pilot of topical hydrogen-rich water on facial skin in 15 healthy adults. Reported a statistically significant reduction in pore visibility and consistent directional improvements in pigmentation, wrinkle severity, and biological skin age estimates.
  • Ohsawa I et al. (2007), Nature Medicine. PMID: 17486089. The foundational paper proposing molecular hydrogen as a selective antioxidant — the conceptual basis for every study above and the most-cited single paper in the field.

References

  1. Kuang X, Liang Z, Shan M, Hao Y, Xia Y, Xia C, Liu H, Chen Q, Chang G, He Q, Wang Y. Exploratory Evaluation of Hydrogen-Rich Water Therapy for Keloid Management: A Double-Blinded Randomized Pilot Trial. Aesthetic Plastic Surgery. 2026;50(9):3448-3459. PMID: 41545661. DOI: 10.1007/s00266-025-05512-5.
  2. Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, Yamagata K, Katsura K, Katayama Y, Asoh S, Ohta S. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nature Medicine. 2007;13(6):688-694. PMID: 17486089. DOI: 10.1038/nm1577.
  3. Hori F, Sobue S, Inoue C, Murakumo Y, Ichihara M. Molecular Hydrogen Attenuates Chronic Inflammation and Delays the Onset of Ultraviolet B-Induced Skin Carcinogenesis in Mice. International Journal of Molecular Sciences. 2026;27(2):635. PMID: 41596287. DOI: 10.3390/ijms27020635.
  4. Wu Y, Wang X, Sun Y, Duan Y, Zhang M, Sang H, Yu P, Kong Q. Hydrogen ameliorates psoriasis-like skin inflammation via inhibiting the cGAS-STING pathway. Clinical and Experimental Immunology. 2026;220(1). PMID: 41533764. DOI: 10.1093/cei/uxaf081.
  5. Zhao P, Dang Z, Liu M, Guo D, Luo R, Zhang M, Xie F, Zhang X, Wang Y, Pan S, Ma X. Molecular hydrogen promotes wound healing by inducing early epidermal stem cell proliferation and extracellular matrix deposition. Inflammation and Regeneration. 2023;43(1):22. PMID: 36973725. DOI: 10.1186/s41232-023-00271-9.
  6. Zhang X, Yu P, Hong N, Liu F, Shan Y, Wu Y, An B, Sang H, Kong Q. Effect and mechanism of hydrogen-rich bath on mice with imiquimod-induced psoriasis. Experimental Dermatology. 2023;32(10):1674-1681. PMID: 37391861. DOI: 10.1111/exd.14872.
  7. Debkowska N, Niczyporuk M, Surazynski A, Wolosik K. Topically Applied Molecular Hydrogen Normalizes Skin Parameters Associated with Oxidative Stress: A Pilot Study. Antioxidants (Basel). 2025;14(6):729. PMID: 40563361. DOI: 10.3390/antiox14060729.
  8. Zanini D, Todorovic N, Korovljev D, Stajer V, Ostojic J, Purac J, Kojic D, Vukasinovic E, Djordjievski S, Sopic M, Guzonjic A, Ninic A, Erceg S, Ostojic SM. The effects of 6-month hydrogen-rich water intake on molecular and phenotypic biomarkers of aging in older adults aged 70 years and over: A randomized controlled pilot trial. Experimental Gerontology. 2021;155:111574. PMID: 34601077. DOI: 10.1016/j.exger.2021.111574.
  9. Guo N, Zhang Y. Progress in the Application of Molecular Hydrogen in Medical Skin Cosmetology. Clinical, Cosmetic and Investigational Dermatology. 2025;18:511-523. PMID: 40061044. DOI: 10.2147/CCID.S500255.
  10. Bajgai J, Lee KJ, Rahman MH, Fadriquela A, Kim CS. Role of Molecular Hydrogen in Skin Diseases and its Impact in Beauty. Current Pharmaceutical Design. 2021;27(5):737-746. PMID: 32981497. DOI: 10.2174/1381612826666200925124235.

Holy Hydrogen products, including the Lourdes Hydrofix Premium Edition, are not medical devices and are not intended to diagnose, treat, cure, or prevent any disease. All information on this site is provided for educational and general wellness purposes only and should not be considered medical advice. Always consult a qualified healthcare provider before beginning any new wellness practice, especially if you have a medical condition, are pregnant or nursing, or take prescription medications.

Share Tweet Pin it
Back to blog